Elevated serum PRL levels have been reported in patients with SLE, and hyperprolactinaemia occurs in approximately 15–31% of patients with SLE, and these elevated PRL levels do appear to correlate with clinical disease activity, as well as antinuclear antibody and anti-dsDNA titreS [7–9]. The gene discussed is PRL; the disease is systemic lupus erythematosus.